Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 63 | 2026 | 432 | 14.320 |
Why?
|
| Homosexuality, Male | 28 | 2026 | 83 | 6.830 |
Why?
|
| Prisoners | 17 | 2026 | 31 | 5.980 |
Why?
|
| Sexual and Gender Minorities | 16 | 2023 | 49 | 5.690 |
Why?
|
| Pre-Exposure Prophylaxis | 9 | 2026 | 67 | 4.740 |
Why?
|
| Substance-Related Disorders | 10 | 2025 | 102 | 4.520 |
Why?
|
| Anti-HIV Agents | 11 | 2026 | 102 | 4.320 |
Why?
|
| Sexually Transmitted Diseases | 12 | 2025 | 35 | 3.810 |
Why?
|
| Sexual Behavior | 21 | 2025 | 100 | 3.780 |
Why?
|
| Male | 68 | 2026 | 3671 | 3.010 |
Why?
|
| Humans | 86 | 2026 | 6794 | 2.860 |
Why?
|
| Adult | 50 | 2026 | 2113 | 2.540 |
Why?
|
| Bisexuality | 9 | 2018 | 20 | 2.290 |
Why?
|
| Sexual Partners | 13 | 2022 | 49 | 2.100 |
Why?
|
| Continuity of Patient Care | 6 | 2022 | 19 | 1.970 |
Why?
|
| Los Angeles | 26 | 2026 | 321 | 1.860 |
Why?
|
| Female | 43 | 2025 | 4060 | 1.790 |
Why?
|
| Transgender Persons | 7 | 2025 | 24 | 1.740 |
Why?
|
| Risk-Taking | 12 | 2022 | 77 | 1.590 |
Why?
|
| Middle Aged | 33 | 2025 | 2108 | 1.570 |
Why?
|
| Prisons | 11 | 2020 | 25 | 1.490 |
Why?
|
| United States | 23 | 2024 | 1019 | 1.370 |
Why?
|
| Peer Group | 5 | 2026 | 34 | 1.310 |
Why?
|
| Young Adult | 16 | 2026 | 567 | 1.280 |
Why?
|
| Condoms | 9 | 2018 | 41 | 1.270 |
Why?
|
| Unsafe Sex | 7 | 2020 | 21 | 1.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 153 | 1.010 |
Why?
|
| Central Nervous System Stimulants | 2 | 2022 | 10 | 0.910 |
Why?
|
| African Americans | 3 | 2014 | 264 | 0.870 |
Why?
|
| Racism | 2 | 2022 | 49 | 0.860 |
Why?
|
| Siblings | 1 | 2023 | 7 | 0.810 |
Why?
|
| Safe Sex | 5 | 2018 | 9 | 0.800 |
Why?
|
| Criminals | 3 | 2020 | 7 | 0.780 |
Why?
|
| Cannabis | 1 | 2023 | 9 | 0.770 |
Why?
|
| Addiction Medicine | 1 | 2022 | 1 | 0.760 |
Why?
|
| HIV Seropositivity | 4 | 2014 | 25 | 0.760 |
Why?
|
| Income Tax | 1 | 2022 | 1 | 0.750 |
Why?
|
| Psychiatry | 1 | 2022 | 10 | 0.750 |
Why?
|
| Minority Groups | 2 | 2020 | 63 | 0.710 |
Why?
|
| Health Equity | 1 | 2022 | 24 | 0.710 |
Why?
|
| Adolescent | 15 | 2022 | 869 | 0.690 |
Why?
|
| Surveys and Questionnaires | 9 | 2020 | 280 | 0.670 |
Why?
|
| Social Support | 6 | 2026 | 67 | 0.670 |
Why?
|
| Risk Reduction Behavior | 3 | 2022 | 17 | 0.660 |
Why?
|
| Patient Selection | 1 | 2020 | 40 | 0.660 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 3 | 0.650 |
Why?
|
| Trust | 1 | 2020 | 33 | 0.650 |
Why?
|
| Patient Participation | 1 | 2020 | 32 | 0.640 |
Why?
|
| Transsexualism | 2 | 2010 | 5 | 0.630 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 145 | 0.620 |
Why?
|
| Heterosexuality | 2 | 2011 | 6 | 0.610 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 72 | 0.590 |
Why?
|
| Patient Navigation | 1 | 2018 | 7 | 0.560 |
Why?
|
| Behavior Therapy | 2 | 2018 | 10 | 0.540 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 71 | 0.510 |
Why?
|
| Aged | 11 | 2023 | 1539 | 0.500 |
Why?
|
| Interviews as Topic | 4 | 2026 | 77 | 0.480 |
Why?
|
| Crime | 2 | 2020 | 7 | 0.470 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 35 | 0.460 |
Why?
|
| Qualitative Research | 4 | 2026 | 82 | 0.460 |
Why?
|
| Incidence | 4 | 2026 | 197 | 0.450 |
Why?
|
| Social Identification | 2 | 2016 | 8 | 0.440 |
Why?
|
| Health Status Disparities | 3 | 2012 | 83 | 0.430 |
Why?
|
| HIV Seroprevalence | 3 | 2004 | 3 | 0.420 |
Why?
|
| Prevalence | 10 | 2017 | 259 | 0.410 |
Why?
|
| California | 6 | 2024 | 230 | 0.400 |
Why?
|
| HIV | 4 | 2022 | 16 | 0.400 |
Why?
|
| Medicaid | 2 | 2024 | 19 | 0.400 |
Why?
|
| Medication Adherence | 2 | 2026 | 64 | 0.380 |
Why?
|
| Prejudice | 2 | 2009 | 28 | 0.360 |
Why?
|
| Income | 3 | 2022 | 30 | 0.360 |
Why?
|
| Risk Factors | 11 | 2018 | 767 | 0.360 |
Why?
|
| Anti-Retroviral Agents | 2 | 2022 | 28 | 0.340 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 293 | 0.320 |
Why?
|
| Terminology as Topic | 1 | 2010 | 15 | 0.320 |
Why?
|
| Logistic Models | 5 | 2020 | 165 | 0.310 |
Why?
|
| Sex Work | 1 | 2009 | 10 | 0.310 |
Why?
|
| Preventive Health Services | 1 | 2009 | 21 | 0.300 |
Why?
|
| Health Surveys | 2 | 2011 | 75 | 0.290 |
Why?
|
| Health Promotion | 2 | 2018 | 89 | 0.290 |
Why?
|
| Age Factors | 5 | 2018 | 193 | 0.290 |
Why?
|
| Self Concept | 1 | 2008 | 10 | 0.290 |
Why?
|
| Research | 1 | 2008 | 26 | 0.270 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 83 | 0.270 |
Why?
|
| Truth Disclosure | 2 | 2012 | 10 | 0.270 |
Why?
|
| Mass Screening | 4 | 2020 | 116 | 0.270 |
Why?
|
| Attitude | 1 | 2006 | 15 | 0.250 |
Why?
|
| Delayed-Action Preparations | 1 | 2026 | 8 | 0.240 |
Why?
|
| Injections | 1 | 2026 | 20 | 0.240 |
Why?
|
| Computer Simulation | 1 | 2026 | 26 | 0.240 |
Why?
|
| Mobile Applications | 1 | 2026 | 4 | 0.240 |
Why?
|
| Smartphone | 1 | 2026 | 6 | 0.240 |
Why?
|
| Mentors | 1 | 2026 | 19 | 0.240 |
Why?
|
| Allostasis | 2 | 2017 | 6 | 0.220 |
Why?
|
| Methamphetamine | 2 | 2022 | 6 | 0.220 |
Why?
|
| Naloxone | 1 | 2024 | 22 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 29 | 0.220 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 17 | 0.220 |
Why?
|
| Ambulatory Care | 1 | 2024 | 21 | 0.220 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 23 | 0.220 |
Why?
|
| Criminal Law | 2 | 2021 | 6 | 0.220 |
Why?
|
| HIV-1 | 4 | 2014 | 36 | 0.220 |
Why?
|
| Ambulatory Care Facilities | 1 | 2004 | 25 | 0.220 |
Why?
|
| Focus Groups | 3 | 2018 | 46 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 87 | 0.210 |
Why?
|
| Feasibility Studies | 1 | 2023 | 44 | 0.200 |
Why?
|
| Mental Health | 2 | 2022 | 70 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2023 | 16 | 0.200 |
Why?
|
| Social Stigma | 2 | 2021 | 58 | 0.200 |
Why?
|
| Medicare | 1 | 2023 | 57 | 0.190 |
Why?
|
| Emigration and Immigration | 1 | 2002 | 13 | 0.190 |
Why?
|
| Sustained Virologic Response | 2 | 2022 | 7 | 0.190 |
Why?
|
| RNA, Viral | 4 | 2018 | 20 | 0.190 |
Why?
|
| Illinois | 4 | 2024 | 4 | 0.180 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 7 | 0.180 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 506 | 0.180 |
Why?
|
| Blood Pressure Determination | 1 | 2001 | 9 | 0.170 |
Why?
|
| Hypercholesterolemia | 1 | 2001 | 13 | 0.170 |
Why?
|
| Health Behavior | 3 | 2012 | 65 | 0.170 |
Why?
|
| Gender Identity | 2 | 2012 | 17 | 0.170 |
Why?
|
| Cholesterol | 1 | 2001 | 37 | 0.170 |
Why?
|
| Sexuality | 2 | 2018 | 16 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 36 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 197 | 0.160 |
Why?
|
| Sex Factors | 2 | 2011 | 155 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 7 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2017 | 18 | 0.150 |
Why?
|
| Hypertension | 1 | 2001 | 147 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2019 | 48 | 0.150 |
Why?
|
| Mortality | 2 | 2017 | 43 | 0.150 |
Why?
|
| Culturally Competent Care | 1 | 2018 | 8 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 32 | 0.140 |
Why?
|
| Case Management | 1 | 2018 | 6 | 0.140 |
Why?
|
| Coitus | 2 | 2016 | 9 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 497 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 17 | 0.130 |
Why?
|
| Intimate Partner Violence | 1 | 2017 | 10 | 0.130 |
Why?
|
| Time Factors | 4 | 2017 | 321 | 0.130 |
Why?
|
| Personal Autonomy | 1 | 2017 | 6 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 33 | 0.130 |
Why?
|
| Community Health Services | 1 | 2017 | 35 | 0.130 |
Why?
|
| Religion | 1 | 2017 | 16 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 8 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 268 | 0.130 |
Why?
|
| Self Efficacy | 1 | 2016 | 18 | 0.120 |
Why?
|
| Unemployment | 1 | 2016 | 2 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 8 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 20 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2015 | 46 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 172 | 0.110 |
Why?
|
| Counseling | 2 | 2018 | 29 | 0.110 |
Why?
|
| Stress, Psychological | 2 | 2012 | 60 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2013 | 46 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2012 | 60 | 0.090 |
Why?
|
| Viral Load | 3 | 2022 | 26 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 1 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 12 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 14 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 16 | 0.080 |
Why?
|
| Hierarchy, Social | 1 | 2010 | 1 | 0.080 |
Why?
|
| Culture | 1 | 2010 | 15 | 0.080 |
Why?
|
| Urban Population | 2 | 2016 | 85 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 5 | 0.080 |
Why?
|
| Consumer Behavior | 1 | 2009 | 4 | 0.080 |
Why?
|
| Community Networks | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cultural Competency | 1 | 2009 | 9 | 0.070 |
Why?
|
| Demography | 1 | 2009 | 26 | 0.070 |
Why?
|
| Contact Tracing | 1 | 2009 | 4 | 0.070 |
Why?
|
| Decision Making | 1 | 2009 | 25 | 0.070 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 2 | 0.070 |
Why?
|
| History, 17th Century | 1 | 2009 | 1 | 0.070 |
Why?
|
| History, 18th Century | 1 | 2009 | 1 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2009 | 4 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 13 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2009 | 61 | 0.070 |
Why?
|
| Motivation | 1 | 2008 | 42 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2020 | 285 | 0.070 |
Why?
|
| Philadelphia | 2 | 2018 | 2 | 0.070 |
Why?
|
| Depression | 2 | 2023 | 128 | 0.070 |
Why?
|
| HIV Antibodies | 2 | 2004 | 7 | 0.060 |
Why?
|
| Homophobia | 2 | 2018 | 4 | 0.060 |
Why?
|
| Age Distribution | 2 | 2003 | 45 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2024 | 15 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2004 | 1 | 0.050 |
Why?
|
| Anonymous Testing | 1 | 2004 | 1 | 0.050 |
Why?
|
| Washington | 1 | 2004 | 2 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 17 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 16 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 26 | 0.050 |
Why?
|
| Marital Status | 1 | 2003 | 10 | 0.050 |
Why?
|
| Texas | 1 | 2022 | 9 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2003 | 82 | 0.050 |
Why?
|
| Child | 1 | 2004 | 524 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 1999 | 11 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1999 | 23 | 0.050 |
Why?
|
| Pregnancy | 3 | 1999 | 599 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2001 | 8 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 331 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 25 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 19 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1997 | 17 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 127 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 65 | 0.040 |
Why?
|
| Aging | 1 | 2001 | 105 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 17 | 0.040 |
Why?
|
| Water Pollution | 1 | 1999 | 1 | 0.040 |
Why?
|
| Water Microbiology | 1 | 1999 | 2 | 0.040 |
Why?
|
| Swimming | 1 | 1999 | 5 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 41 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 7 | 0.040 |
Why?
|
| Cocaine | 1 | 2019 | 22 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 14 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 58 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 110 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 98 | 0.040 |
Why?
|
| Alcoholism | 2 | 2013 | 25 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2019 | 500 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 42 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 147 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 220 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 83 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 82 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 169 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 7 | 0.030 |
Why?
|
| Intention | 1 | 2016 | 20 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 6 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 108 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 8 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 8 | 0.030 |
Why?
|
| Urban Health | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 48 | 0.030 |
Why?
|
| Social Class | 1 | 2012 | 46 | 0.020 |
Why?
|
| Carrier State | 1 | 2010 | 3 | 0.020 |
Why?
|
| Behavior | 1 | 2010 | 3 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 13 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 5 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 89 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 26 | 0.020 |
Why?
|
| beta 2-Microglobulin | 2 | 1999 | 2 | 0.020 |
Why?
|
| Neopterin | 2 | 1999 | 2 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 38 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1999 | 48 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1997 | 7 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 44 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 61 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 13 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 14 | 0.010 |
Why?
|
| Oceans and Seas | 1 | 1999 | 1 | 0.010 |
Why?
|
| Sewage | 1 | 1999 | 1 | 0.010 |
Why?
|
| Enterobacteriaceae | 1 | 1999 | 3 | 0.010 |
Why?
|
| Leisure Activities | 1 | 1999 | 6 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1999 | 2 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1999 | 5 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1999 | 4 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 11 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1997 | 21 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1997 | 14 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 45 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 187 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 199 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 91 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1997 | 681 | 0.010 |
Why?
|